Lübbert, Michael
Universitätsklinikum Freiburg,
Germany
2025 Rank: 122997
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 2214 out of 166615 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 122997 | 122637 |
| Total Cites | 1381 | 1587 |
| H-index | 17 | 19 |
| Hm-index | 4 | 4 |
| Number of Single Authored Papers | 7 | 7 |
| Total Cites to Single Authored Papers | 1 | 1 |
| Number of Single+First Authored Papers | 48 | 48 |
| Total Cites to Single+First Authored Papers | 42 | 51 |
| Number of Single+First+Last Authored Papers | 158 | 158 |
| Total Cites to Single+First+Last Authored Papers | 245 | 266 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 1105 | 1216 |
| Ratio of Total Citations to Distinct Citing Papers | 1.25 | 1.31 |
| Self-Citation Percentage |
12.98%
|
|
Lübbert, Michael
Universitätsklinikum Freiburg,
Germany
2024 Rank: 104508
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 2020 out of 157372 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 104508 | 93887 |
| Total Cites | 1538 | 1778 |
| H-index | 18 | 21 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 7 | 7 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 48 | 48 |
| Total Cites to Single+First Authored Papers | 65 | 78 |
| Number of Single+First+Last Authored Papers | 152 | 152 |
| Total Cites to Single+First+Last Authored Papers | 270 | 301 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 1138 | 1240 |
| Ratio of Total Citations to Distinct Citing Papers | 1.35 | 1.43 |
| Self-Citation Percentage |
13.50%
|
|
Lübbert, Michael
Universitätsklinikum Freiburg,
Germany
2023 Rank: 67527
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1517 out of 147556 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 67527 | 65385 |
| Total Cites | 1624 | 1870 |
| H-index | 19 | 21 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 7 | 7 |
| Total Cites to Single Authored Papers | 2 | 2 |
| Number of Single+First Authored Papers | 47 | 47 |
| Total Cites to Single+First Authored Papers | 72 | 82 |
| Number of Single+First+Last Authored Papers | 147 | 147 |
| Total Cites to Single+First+Last Authored Papers | 312 | 346 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 1232 | 1354 |
| Ratio of Total Citations to Distinct Citing Papers | 1.32 | 1.38 |
| Self-Citation Percentage |
13.16%
|
|
Lübbert, Michael
Universitätsklinikum Freiburg,
Germany
2022 Rank: 46905
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1186 out of 138599 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 46905 | 45936 |
| Total Cites | 1836 | 2158 |
| H-index | 21 | 23 |
| Hm-index | 5 | 6 |
| Number of Single Authored Papers | 7 | 7 |
| Total Cites to Single Authored Papers | 2 | 2 |
| Number of Single+First Authored Papers | 47 | 47 |
| Total Cites to Single+First Authored Papers | 111 | 120 |
| Number of Single+First+Last Authored Papers | 144 | 144 |
| Total Cites to Single+First+Last Authored Papers | 353 | 396 |
| Composite Score | 2 | 3 |
| Number of Distinct Citing Papers | 1338 | 1472 |
| Ratio of Total Citations to Distinct Citing Papers | 1.37 | 1.47 |
| Self-Citation Percentage |
14.92%
|
|
Lübbert, Michael
Universitäts Klinikum Freiburg und Medizinische Fakultät,
Germany
2021 Rank: 55432
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1285 out of 127911 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 55432 | 53704 |
| Total Cites | 2555 | 2964 |
| H-index | 25 | 27 |
| Hm-index | 6 | 6 |
| Number of Single Authored Papers | 7 | 7 |
| Total Cites to Single Authored Papers | 3 | 3 |
| Number of Single+First Authored Papers | 47 | 47 |
| Total Cites to Single+First Authored Papers | 138 | 154 |
| Number of Single+First+Last Authored Papers | 141 | 141 |
| Total Cites to Single+First+Last Authored Papers | 476 | 511 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 1881 | 2076 |
| Ratio of Total Citations to Distinct Citing Papers | 1.36 | 1.43 |
| Self-Citation Percentage |
13.80%
|
|
Lübbert, Michael
Universität Freiburg im Breisgau,
Germany
2020 Rank: 62082
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1347 out of 108509 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 62082 | 63694 |
| Total Cites | 1823 | 2159 |
| H-index | 22 | 23 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 7 | 7 |
| Total Cites to Single Authored Papers | 1 | 1 |
| Number of Single+First Authored Papers | 46 | 46 |
| Total Cites to Single+First Authored Papers | 98 | 115 |
| Number of Single+First+Last Authored Papers | 137 | 137 |
| Total Cites to Single+First+Last Authored Papers | 363 | 402 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 1395 | 1553 |
| Ratio of Total Citations to Distinct Citing Papers | 1.31 | 1.39 |
| Self-Citation Percentage |
15.56%
|
|
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.